02329.HK
Glory Health Industry Limited
HKSE · Real Estate · Real Estate - Development · CN
HKD 0.10
+1.98%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.7B | 1.0B | 2.7B | 2.5B | 3.9B |
| Cost of Revenue | 3.5B | 1.3B | 2.1B | 2.6B | 3.8B |
| Gross Profit | 247.5M | (308.1M) | 555.6M | (50.3M) | 113.5M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 521.0M | 243.6M | 277.4M | 429.9M | 460.6M |
| General & Admin Expense | 374.0M | 185.0M | 189.0M | 346.4M | 364.3M |
| Selling & Marketing Expense | 146.9M | 58.6M | 88.4M | 83.5M | 96.3M |
| Other Expenses | 278.8M | 219.1M | 31.5M | (18.7M) | 68.1M |
| Total Operating Expenses | 799.7M | 462.7M | 308.9M | 411.1M | 528.7M |
| Cost and Expenses | 4.3B | 1.8B | 2.5B | 3.0B | 4.3B |
| Operating Income (EBIT) | (524.1M) | (770.8M) | 246.7M | (461.4M) | (415.1M) |
| Non-Operating | |||||
| Interest Income | 71.4M | 243.0K | 65.6M | 73.6M | 74.3M |
| Interest Expense | 1.8B | 847.3M | 1.1B | 449.3M | 451.6M |
| Net Interest Income | (1.8B) | (847.1M) | (996.1M) | (375.7M) | (377.3M) |
| Other Non-Op Income/Expense | (2.8B) | (1.1B) | (1.7B) | (194.1M) | (675.2M) |
| Non-Operating Income (excl Interest) | — | — | 710.8M | (255.2M) | 223.6M |
| EBT (Pre-Tax Income) | (3.3B) | (1.9B) | (1.4B) | (678.6M) | (1.1B) |
| Income Tax Expense | (114.5M) | 132.2M | (20.8M) | (85.1M) | (95.1M) |
| Bottom Line | |||||
| Net Income | (3.1B) | (1.8B) | (1.2B) | (564.0M) | (912.8M) |
| Earnings from Cont. Ops | (3.2B) | (1.8B) | (1.4B) | (593.5M) | (995.3M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (3.1B) | (1.8B) | (1.2B) | (564.0M) | (912.8M) |
| Per Share | |||||
| Basic EPS | (HK$0.69) | (HK$0.41) | (HK$0.28) | (HK$0.13) | (HK$0.21) |
| Diluted EPS | (HK$0.69) | (HK$0.41) | (HK$0.28) | (HK$0.13) | (HK$0.21) |
| Revenue Per Share | HK$0.84 | HK$0.23 | HK$0.61 | HK$0.56 | HK$0.90 |
| Shares | |||||
| Basic Shares Outstanding | 4.4B | 4.4B | 4.4B | 4.4B | 4.3B |
| Diluted Shares Outstanding | 4.4B | 4.4B | 4.4B | 4.4B | 4.4B |
| Profitability Metrics | |||||
| EBITDA | (385.4M) | (696.9M) | 295.1M | (145.9M) | (325.9M) |
| D&A | 166.9M | 73.9M | 76.6M | 83.5M | 89.2M |
| EBIT | (552.3M) | (770.8M) | 218.6M | (229.4M) | (415.1M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025